Dickkopf-3 in Human Malignant Tumours: A Clinical Viewpoint
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Ju | - |
dc.contributor.author | Nguyen, Que Thanh Thanh | - |
dc.contributor.author | Lee, Mooyul | - |
dc.date.accessioned | 2022-01-21T01:40:55Z | - |
dc.date.available | 2022-01-21T01:40:55Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.issn | 1791-7530 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54034 | - |
dc.description.abstract | Dickkopf-3 (DKK3), also known as REIC, is a secreted glycoprotein. DKK3 is aberrantly expressed in various types of human malignant tumours. Promoter methylation status, intracellular protein expression, and protein expression in tumour vessels are significantly correlated with clinical prognostic factors, including survival. In malignant cells, DKK3 is involved in the induction of apoptosis, inhibition of invasion, and remodelling of tumour vasculature. These activities are carried out via the regulation of the beta-catenin signalling and c-Jun N-terminal kinase-dependent cellular pathway, both of which are critical for carcinogenesis. This review explores the potential value of DKK3 as a clinical biomarker and a therapeutic candidate in human malignancies. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.title | Dickkopf-3 in Human Malignant Tumours: A Clinical Viewpoint | - |
dc.type | Article | - |
dc.identifier.doi | 10.21873/anticanres.14617 | - |
dc.identifier.bibliographicCitation | ANTICANCER RESEARCH, v.40, no.11, pp 5969 - 5979 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000582681900002 | - |
dc.identifier.scopusid | 2-s2.0-85094855894 | - |
dc.citation.endPage | 5979 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 5969 | - |
dc.citation.title | ANTICANCER RESEARCH | - |
dc.citation.volume | 40 | - |
dc.type.docType | Review | - |
dc.publisher.location | 그리이스 | - |
dc.subject.keywordAuthor | Dickkopf-3 | - |
dc.subject.keywordAuthor | clinical biomarker | - |
dc.subject.keywordAuthor | malignant tumour | - |
dc.subject.keywordAuthor | therapeutics | - |
dc.subject.keywordAuthor | review | - |
dc.subject.keywordPlus | REIC/DKK-3 GENE-THERAPY | - |
dc.subject.keywordPlus | ANTAGONIST FAMILY GENES | - |
dc.subject.keywordPlus | WNT SIGNALING PATHWAY | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | REDUCED EXPRESSION | - |
dc.subject.keywordPlus | BETA-CATENIN | - |
dc.subject.keywordPlus | PROMOTER METHYLATION | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | DKK-3 EXPRESSION | - |
dc.subject.keywordPlus | REIC GENE | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.